| | |
Mark to Market | Mobis Philipose, Ravi Ananthanarayanan and Vatsala Kamat 12:59 AM | October 23,2009
Biocon is evidently on a steady track. But whether it makes it to the big league will depend on success in research in the next year or two
|
|
Seema Singh 11:16 PM | October 22,2009
Consolidated total income increased to Rs592.35 crore during the September quarter from Rs457.73 crore in the year-ago period
|
|
Bloomberg 12:05 AM | September 30,2009
The product is in the third and final stage of clinical studies, managing director Kiran Mazumdar- Shaw said
FIND MORE ARTICLES ON:
Biocon Oral Insulin
|
|
PTI 09:22 PM | September 11,2009
Biocon, AIA Engineering, Allied Digital Services, AurinoPro Solutions and construction materials company Birla feature in the league of 200 companies
|
|
Seema Singh 11:36 PM | September 09,2009
Study finds one in four Canadian biotech firms has some form of partnership in the developing countries
|
|
12:38 AM | August 27,2009
United Stock Exchange talks to financial investors; commerce minister to present Foreign Trade Policy on Thursday; advertisers go back in time to bring in customers
|
|
Sumeet Chatterjee / Reuters 11:03 AM | August 26,2009
Biocon is talking to a few companies to sign a licensing pact to launch its innovative oral insulin in global markets, including in India
|
|
12:41 AM | July 24,2009
Maruti’s profits grow for the first time in six quarters. But does this mean it has come out of the downturn? For more watch The Mint Report
|
|
Seema Singh 09:05 PM | July 23,2009
Analysts say Biocon also gained from steady business in its biopharmaceutical division as well as good cost control and recovery in its contract services operations, Syngene and Clinigene
|
|
Seema Singh 01:15 AM | July 15,2009
Shantha Biotechnics Ltd’s majority stakeholder plans to offload half its holding, but the identity of the likely buyer is something that even founder K.I. Varaprasad Reddy claims he doesn’t know
|
|
PTI 01:09 PM | June 29,2009
Mylan will have exclusive commercialisation rights in the US, Canada, Japan, Australia, New Zealand and in the European Union countries through a profit sharing arrangement with Biocon
|
|
C.H. Unnikrishnan 12:11 AM | June 18,2009
A funding squeeze in the UK that has forced firms and institutes to look for low-cost alternatives, coupled with capabilities in drug research and manufacturing, has doubled India’s attractiveness
|
|
PTI 11:44 PM | April 28,2009
MTM is an accounting practice of assigning a value to a position held in a financial instrument based on the current market price for that instrument
|
|
PTI 03:15 PM | March 23,2009
Facility will be dedicated to the discovery and development of new drugs
|
|
Khushboo Narayan 11:05 PM | March 08,2009
Survey shows 73% firms want their benefits to be more relevant to staff need
|
|